Method and apparatus for medical imaging using differencing of multiple fluorophores

Patent metadata

Field	Value
Publication number	US-11937951-B2
Application number	US-202318159495-A
Country	US
Kind code	B2
Filing date	Jan 25, 2023
Priority date	Feb 13, 2013
Publication date	Mar 26, 2024
Grant date	Mar 26, 2024

Abstract

A method of generating corrected fluorescence data of concentrations of a targeted fluorophore in tissue of a subject includes administering first and second fluorescent contrast agents to the subject, the first contrast agent targeted to tissue of interest, the second agent untargeted. The tissue is illuminated with light of a first stimulus wavelength and first data is acquired at an appropriate emissions wavelength; the tissue is illuminated at a second stimulus wavelength and second data is acquired at a second emissions wavelength associated with the second agent, the first and second emissions wavelength differ. Difference data is generated by subtracting the second data from the first data. A system provides for stimulus and capture at multiple wavelengths, with image storage memory and subtraction code, to perform the method. Corrected data may form an fluorescence image, or is used to generate fluorescence tomographic images.

First claim

What is claimed is:

1. A method of generating corrected fluorescence data of concentrations of a targeted fluorophore in tissue of a subject, comprising:
administering a first fluorescent contrast agent to the subject, the first fluorescent contrast agent selected from the group consisting of tissue-targeted agents containing the targeted fluorophore and agents containing a tissue-targeted prodrug metabolizable into the targeted fluorophore;
administering a second fluorescent contrast agent to the subject, the second fluorescent contrast agent having tissue affinity differing from a tissue affinity of the first fluorescent contrast agent and containing a second fluorophore;
illuminating tissue of the subject with light of a first stimulus wavelength;
acquiring first data at a first emissions wavelength associated with the targeted fluorophore;
illuminating tissue of the subject with light of a second stimulus wavelength;
acquiring second data at a second emissions wavelength associated with the second fluorophore, the second emissions wavelength different from the first emissions wavelength; and
subtracting the second data from the first data to provide the corrected fluorescence data;
wherein the targeted fluorophore emits light of the first emissions wavelength when stimulated by light of the first stimulus wavelength, and the second fluorophore emits light of the second emissions wavelength when stimulated by light of the second stimulus wavelength; and
reconstructing bound fluorophore concentrations of a voxel-based three dimensional model of distribution of bound targeted fluorophore concentration in tissue from the corrected fluorescence data.

2. The method of claim 1 wherein each of the first data, second data, and corrected fluorescence data, are digital images.

3. The method of claim 1 wherein the first data represents data acquired by a multichannel photodetector with the tissue illuminated at each of a plurality of points, and further comprising reconstructing a tomographic model of fluorophore distribution in the tissue.

4. The method of claim 2 further comprising scaling at least one member of the group consisting of the second data and the first data prior to the step of subtracting.

5. The method of claim 3 further comprising scaling at least one member of the group consisting of the second data and the first data prior to the step of subtracting.

6. The method of claim 4 wherein the first and second emissions wavelengths are different.

7. The method of claim 6 wherein the first and second stimulus wavelengths are different.

8. The method of claim 4 wherein the first fluorescent contrast agent comprises a prodrug metabolizable into the targeted fluorophore.

9. The method of claim 5 wherein the first fluorescent contrast agent comprises a prodrug metabolizable into the targeted fluorophore.

10. The method of claim 4 wherein the first fluorescent contrast agent comprises a fluorescent-labeled antibody.

11. The method of claim 5 wherein the first fluorescent contrast agent comprises a fluorescent-labeled antibody.

12. The method of claim 8 further comprising:
obtaining a white-light image, and
superimposing the corrected difference data on the white-light image.

13. A method of identifying tumor tissue of a subject during surgery comprising:
administering a first fluorescent contrast agent to the subject, the first fluorescent contrast agent selected from the group consisting of fluorescent contrast agents targeted to the tumor tissue and containing a targeted fluorophore, and agents containing a prodrug metabolizable by the tumor tissue into the targeted fluorophore;
administering a second fluorescent contrast agent to the subject, the second fluorescent contrast agent having tissue affinity differing from a tissue affinity of the first fluorescent contrast agent and containing a second fluorophore;
illuminating tissue of the subject with light of a first stimulus wavelength;
acquiring first data at a first emissions wavelength associated with the targeted fluorophore;
acquiring second data at a second emissions wavelength associated with the second fluorophore, the second emissions wavelength different from the first emissions wavelength; and
subtracting the second data from the first data to provide corrected fluorescence data;
reconstructing bound fluorophore concentrations of a three-dimensional voxel-based model of tissue of the subject using the corrected fluorescence data; and
wherein the targeted fluorophore emits light of the first emissions wavelength when stimulated by light of the first stimulus wavelength, and the second fluorophore emits light of the second emissions wavelength when stimulated by light of the second stimulus wavelength.

14. The method of claim 13 where the tumor is a glioma.

15. The method of claim 13 where the step of acquiring second data at a second emissions wavelength is obtained while illuminating tissue of the subject with light of a second stimulus wavelength.

Assignees

• Dartmouth College

Inventors

• Tichauer Kenneth
• Holt Robert W
• Leblond Frederic
• Valdes Pablo
• Pogue Brian W
• Paulsen Keith D
• Roberts David W

Classifications

• A61B5/7278 Primary

  Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals · CPC title

• A61B5/0071 Primary

  by measuring fluorescence emission · CPC title

• A61K49/0058

  Antibodies · CPC title

• A61B5/0035

  adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography · CPC title

• A61B5/0062

  Arrangements for scanning · CPC title